Gycyrrhizic acid alleviates atherosclerotic lesions in rats with diabetes mellitus

Gycyrrhizic acid (GA), an inhibitor of high mobility group box 1 (HMGB1), inhibits inflammatory responses and is involved in the occurrence and development of several inflammation-related diseases. However, the role of GA in the atherosclerotic lesions caused by diabetes mellitus (DM) remains unknow...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yaodong, Li, Wei, Zhang, Daimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436226/
https://www.ncbi.nlm.nih.gov/pubmed/34476498
http://dx.doi.org/10.3892/mmr.2021.12395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436226/
https://www.ncbi.nlm.nih.gov/pubmed/34476498
http://dx.doi.org/10.3892/mmr.2021.12395

Ejemplares similares